Overview
Welcome to Dwaey, specifically on GLICOMEL MR 30mg Tablets/Modified Release page.
This medicine contains an important and useful components, as it consists of Gliclazide.
GLICOMEL MR 30mg is available in the market in concentration 30mg/Tablet and in the form of Tablets/Modified Release.
LAGAP SA is the producer of GLICOMEL MR 30mg and it is imported from UAE, The most popular alternatives of GLICOMEL MR 30mg are listed downward .
Gliclazide stimulates insulin secretion from pancreatic beta-cells, reduces insulin uptake and glucose output by the liver, and increases insulin sensitivity at peripheral target sites. It decreases microthrombosis by partial inhibition of platelet aggregation and adhesion, and by restoring fibrinolysis w/ an increase in tissue plasminogen activator (t-PA) activity.
Monitor blood glucose concentration. May require insulin during metabolic stress. Care when transferring from combination therapy. Increased risk of severe hypoglycaemia in elderly, debilitated patients, patients with hepatic or renal impairment. Risk of hypogylcaemia when caloric intake is deficient, after strenuous exercise, when taken with ethanol or when >1 antidiabetic drug is used.
Type 1 DM, diabetes complicated with ketoacidosis; hypersensitivity; severe renal and hepatic impairment. Pregnancy and lactation.
Pregnancy category: C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
Gliclazide
Gliclazide
Gliclazide
Gliclazide
Gliclazide
Gliclazide
Gliclazide
Gliclazide